Schedule 13G ownership disclosure

Allena Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 018119107

Event date: 2019-12-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,201,828
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001105806-19-000029
Form type
SC 13G
Filer
Allena Pharmaceuticals, Inc.
CIK
CIK 1624658
Filed
Dec 12, 2019
Reporting period
Dec 03, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub